Globular adiponectin elicits neuroprotection by inhibiting NADPH oxidase-mediated oxidative damage in ischemic stroke

Neuroscience

Volumn 248, Issue , 2013, Pages 136-144

  Song, W ^a,b   Huo, T ^a   Guo, F ^a   Wang, H ^a   Wei, H ^a   Yang, Q ^a   Dong, H ^a   Wang, Q ^a   Xiong, L ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b SHAANXI PROVINCIAL PEOPLE S HOSPITAL   (China)

Author keywords

Cerebral ischemia; Globular adiponectin; NADPH oxidase; Oxidative damage; Stroke

Indexed keywords

ADIPONECTIN; CASPASE 3; CATALASE; MALONALDEHYDE; PROTEIN BAX; PROTEIN BCL 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SUPEROXIDE DISMUTASE; ADIPOQ PROTEIN, MOUSE; ANTIOXIDANT; CYBB PROTEIN, MOUSE; MEMBRANE PROTEIN; NEUROPROTECTIVE AGENT;

ADULT ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROPROTECTION; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; BRAIN; C57BL MOUSE; DRUG EFFECTS; ENZYMOLOGY; METABOLISM; NERVE CELL; OXIDATIVE STRESS; REPERFUSION INJURY; STROKE;

ADIPONECTIN; ANIMALS; ANTIOXIDANTS; APOPTOSIS; BRAIN; BRAIN ISCHEMIA; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; NADPH OXIDASE; NEURONS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; REPERFUSION INJURY; STROKE;

EID: 84880146828     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.05.063     Document Type: Article

References (46)

1. Aebi H. Catalase in vitro. Methods Enzymol 1984, 105:121-126.
2. Bedard K., Krause K.H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007, 87:245-313.
3. Chen B., Liao W.Q., Xu N., Xu H., Wen J.Y., Yu C.A., Liu X.Y., Li C.L., Zhao S.M., Campbell W. Adiponectin protects against cerebral ischemia-reperfusion injury through anti-inflammatory action. Brain Res 2009, 1273:129-137.
4. Chen M.P., Tsai J.C., Chung F.M., Yang S.S., Hsing L.L., Shin S.J., Lee Y.J. Hypoadiponectinemia is associated with ischemic cerebrovascular disease. Arterioscler Thromb Vasc Biol 2005, 25:821-826.
5. Chetboun M., Abitbol G., Rozenberg K., Rozenfeld H., Deutsch A., Sampson S.R., Rosenzweig T. Maintenance of redox state and pancreatic beta-cell function: role of leptin and adiponectin. J Cell Biochem 2012, 113:1966-1976.
6. Efstathiou S.P., Tsioulos D.I., Tsiakou A.G., Gratsias Y.E., Pefanis A.V., Mountokalakis T.D. Plasma adiponectin levels and five-year survival after first-ever ischemic stroke. Stroke 2005, 36:1915-1919.
7. Fruebis J., Tsao T.S., Javorschi S., Ebbets-Reed D., Erickson M.R., Yen F.T., Bihain B.E., Lodish H.F. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A 2001, 98:2005-2010.
8. Fukushima J., Kamada Y., Matsumoto H., Yoshida Y., Ezaki H., Takemura T., Saji Y., Igura T., Tsutsui S., Kihara S., Funahashi T., Shimomura I., Tamura S., Kiso S., Hayashi N. Adiponectin prevents progression of steatohepatitis in mice by regulating oxidative stress and Kupffer cell phenotype polarization. Hepatol Res 2009, 39:724-738.
9. Gardener H., Sjoberg C., Crisby M., Goldberg R., Mendez A., Wright C.B., Elkind M.S., Sacco R.L., Rundek T. Adiponectin and carotid intima-media thickness in the northern Manhattan study. Stroke 2012, 43:1123-1125.
10. Guillod-Maximin E., Roy A.F., Vacher C.M., Aubourg A., Bailleux V., Lorsignol A., Penicaud L., Parquet M., Taouis M. Adiponectin receptors are expressed in hypothalamus and colocalized with proopiomelanocortin and neuropeptide Y in rodent arcuate neurons. J Endocrinol 2009, 200:93-105.
11. Hattori Y., Akimoto K., Gross S.S., Hattori S., Kasai K. Angiotensin-II-induced oxidative stress elicits hypoadiponectinaemia in rats. Diabetologia 2005, 48:1066-1074.
12. Jeon B.T., Shin H.J., Kim J.B., Kim Y.K., Lee D.H., Kim K.H., Kim H.J., Kang S.S., Cho G.J., Psilopanagioti A., Papadaki H., Kranioti E.F., Alexandrides T.K., Varakis J.N. Expression of adiponectin and adiponectin receptors in human pituitary gland and brain. Neuroendocrinology 2009, 89:38-47.
13. Kanazawa I., Yamaguchi T., Yano S., Yamauchi M., Yamamoto M., Sugimoto T. Adiponectin and AMP kinase activator stimulate proliferation, differentiation, and mineralization of osteoblastic MC3T3-E1 cells. BMC Cell Biol 2007, 8:51.
14. Kim G.S., Jung J.E., Niizuma K., Chan P.H. CK2 is a novel negative regulator of NADPH oxidase and a neuroprotectant in mice after cerebral ischemia. J Neurosci 2009, 29:14779-14789.
15. Kos K., Harte A.L., da Silva N.F., Tonchev A., Chaldakov G., James S., Snead D.R., Hoggart B., O'Hare J.P., McTernan P.G., Kumar S. Adiponectin and resistin in human cerebrospinal fluid and expression of adiponectin receptors in the human hypothalamus. J Clin Endocrinol Metab 2007, 92:1129-1136.
16. Lambeth J.D. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 2004, 4:181-189.
17. Luo N., Liu J., Chung B.H., Yang Q., Klein R.L., Garvey W.T., Fu Y. Macrophage adiponectin expression improves insulin sensitivity and protects against inflammation and atherosclerosis. Diabetes 2010, 59:791-799.
18. McLarnon J.G., Saint D.A., Quastel D.M. The actions of dimethyl sulfoxide on neuromuscular transmission. Mol Pharmacol 1986, 30:631-638.
19. Moskowitz M.A., Lo E.H., Iadecola C. The science of stroke: mechanisms in search of treatments. Neuron 2010, 67:181-198.
20. Nathan C., Ding A. Snapshot: reactive oxygen intermediates (ROI). Cell 2010, 140:951.
21. Nie H., Xiong L., Lao N., Chen S., Xu N., Zhu Z. Hyperbaric oxygen preconditioning induces tolerance against spinal cord ischemia by upregulation of antioxidant enzymes in rabbits. J Cereb Blood Flow Metab 2006, 26:666-674.
22. Nishimura M., Izumiya Y., Higuchi A., Shibata R., Qiu J., Kudo C., Shin H.K., Moskowitz M.A., Ouchi N. Adiponectin prevents cerebral ischemic injury through endothelial nitric oxide synthase dependent mechanisms. Circulation 2008, 117:216-223.
23. Ogunwobi O.O., Beales I.L. Globular adiponectin, acting via adiponectin receptor-1, inhibits leptin-stimulated oesophageal adenocarcinoma cell proliferation. Mol Cell Endocrinol 2008, 285:43-50.
24. Ouchi N., Kihara S., Arita Y., Maeda K., Kuriyama H., Okamoto Y., Hotta K., Nishida M., Takahashi M., Nakamura T., Yamashita S., Funahashi T., Matsuzawa Y. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999, 100:2473-2476.
25. Ouedraogo R., Wu X., Xu S.Q., Fuchsel L., Motoshima H., Mahadev K., Hough K., Scalia R., Goldstein B.J. Adiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathway. Diabetes 2006, 55:1840-1846.
26. Psilopanagioti A., Papadaki H., Kranioti E.F., Alexandrides T.K., Varakis J.N. Expression of adiponectin and adiponectin receptors in human pituitary gland and brain. Neuroendocrinology 2009, 89:38-47.
27. Qi Y., Takahashi N., Hileman S.M., Patel H.R., Berg A.H., Pajvani U.B., Scherer P.E., Ahima R.S. Adiponectin acts in the brain to decrease body weight. Nat Med 2004, 10:524-529.
28. Qiu G., Wan R., Hu J., Mattson M.P., Spangler E., Liu S., Yau S.Y., Lee T.M., Gleichmann M., Ingram D.K., So K.F., Zou S. Adiponectin protects rat hippocampal neurons against excitotoxicity. Age (Dordr) 2011, 33:155-165.
29. Sasaki M., Kawano T., Saito T., Yuzawa M., Saito T., Ikoma A., Tamemoto H., Kawakami M., Ishikawa S.E. Hypoadiponectinemia in patients with cerebral infarction: comparison with other atherosclerotic disorders. Am J Med Sci 2007, 333:140-144.
30. Shen L., Miao J., Yuan F., Zhao Y., Tang Y., Wang Y., Zhao Y., Yang G.Y. Overexpression of adiponectin promotes focal angiogenesis in the mouse brain following middle cerebral artery occlusion. Gene Ther 2013, 20:93-101.
31. Stott D.J., Welsh P., Rumley A., Robertson M., Ford I., Sattar N., Westendorp R.G., Jukema J.W., Cobbe S.M., Lowe G.D. Adipocytokines and risk of stroke in older people: a nested case-control study. Int J Epidemiol 2009, 38:253-261.
32. Sun J., Tong L., Luan Q., Deng J., Li Y., Li Z., Dong H., Xiong L. Protective effect of delayed remote limb ischemic postconditioning: role of mitochondrial K(ATP) channels in a rat model of focal cerebral ischemic reperfusion injury. J Cereb Blood Flow Metab 2012, 32:851-859.
33. Sun X., He J., Mao C., Han R., Wang Z., Liu Y., Chen Y. Negative regulation of adiponectin receptor 1 promoter by insulin via a repressive nuclear inhibitory protein element. Febs Lett 2008, 582:3401-3407.
34. Tao L., Wang Y., Gao E., Zhang H., Yuan Y., Lau W.B., Chan L., Koch W.J., Ma X.L. Adiponectin: an indispensable molecule in rosiglitazone cardioprotection following myocardial infarction. Circ Res 2010, 106:409-417.
35. Thundyil J., Tang S.C., Okun E., Shah K., Karamyan V.T., Li Y.I., Woodruff T.M., Taylor S.M., Jo D.G., Mattson M.P., Arumugam T.V. Evidence that adiponectin receptor 1 activation exacerbates ischemic neuronal death. Exp Transl Stroke Med 2010, 2:15.
36. Walder C.E., Green S.P., Darbonne W.C., Mathias J., Rae J., Dinauer M.C., Curnutte J.T., Thomas G.R. Ischemic stroke injury is reduced in mice lacking a functional NADPH oxidase. Stroke 1997, 28:2252-2258.
37. Wang J.H., Lee C.J., Lee C.C., Chen Y.C., Lee R.P., Hsu B.G. Fasting adiponectin is inversely correlated with metabolic syndrome in patients with coronary artery disease. Intern Med 2010, 49:739-747.
38. Wang Q., Peng Y., Chen S., Gou X., Hu B., Du J., Lu Y., Xiong L. Pretreatment with electroacupuncture induces rapid tolerance to focal cerebral ischemia through regulation of endocannabinoid system. Stroke 2009, 40:2157-2164.
39. Wang Q., Li X., Chen Y., Wang F., Yang Q., Chen S., Min Y., Li X., Xiong L. Activation of epsilon protein kinase C-mediated anti-apoptosis is involved in rapid tolerance induced by electroacupuncture pretreatment through cannabinoid receptor type 1. Stroke 2011, 42:389-396.
40. Wen J.P., Lv W.S., Yang J., Nie A.F., Cheng X.B., Yang Y., Ge Y., Li X.Y., Ning G. Globular adiponectin inhibits GnRH secretion from GT1-7 hypothalamic GnRH neurons by induction of hyperpolarization of membrane potential. Biochem Biophys Res Commun 2008, 373:756-761.
41. Whitehead J.P., Richards A.A., Hickman I.J., Macdonald G.A., Prins J.B. Adiponectin - a key adipokine in the metabolic syndrome. Diabetes Obes Metab 2006, 8:264-280.
42. Wu L.J., Wu G., Akhavan S.M., Baker A., Jia Y., Fahey F.H., Luo H.R., Feener E.P., Clapham D.E. The voltage-gated proton channel Hv1 enhances brain damage from ischemic stroke. Nat Neurosci 2012, 15:565-573.
43. Yamauchi T., Kamon J., Ito Y., Tsuchida A., Yokomizo T., Kita S., Sugiyama T., Miyagishi M., Hara K., Tsunoda M., Murakami K., Ohteki T., Uchida S., Takekawa S., Waki H., Tsuno N.H., Shibata Y., Terauchi Y., Froguel P., Tobe K., Koyasu S., Taira K., Kitamura T., Shimizu T., Nagai R., Kadowaki T. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003, 423:762-779.
44. Yamauchi T., Nio Y., Maki T., Kobayashi M., Takazawa T., Iwabu M., Okada Iwabu M., Kawamoto S., Kubota N., Kubota T., Ito Y., Kamon J., Tsuchida A., Kumagai K., Kozono H., Hada Y., Ogata H., Tokuyama K., Tsunoda M., Ide T., Murakami K., Awazawa M., Takamoto I., Froguel P., Hara K., Tobe K., Nagai R., Ueki K., Kadowaki T. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med 2007, 13:332-339.
45. Yang Q., Dong H., Deng J., Wang Q., Ye R., Li X., Hu S., Dong H., Xiong L. Sevoflurane preconditioning induces neuroprotection through reactive oxygen species-mediated up-regulation of antioxidant enzymes in rats. Anesth Analg 2011, 112:931-937.
46. Yatomi K., Miyamoto N., Komine-Kobayashi M., Liu M., Oishi H., Arai H., Hattori N., Urabe T. Pathophysiological dual action of adiponectin after transient focal ischemia in mouse brain. Brain Res 2009, 1297:169-176.